QUAZAR AML-001: Evaluating CC-486 as a maintenance therapy for older patients with acute myeloid leukaemia in first remission
Daratumuab, carfilzomib and dexamethasone increases survival in patients with relapsed/refractory multiple myeloma
Exploring the pathogenesis of AML and myelodysplastic syndromes using genome and transcriptome sequencing
Blinatumomab demonstrates superior efficacy compared to chemotherapy in children and young adults with relapsed B-ALL
CAR T-cell therapy in hard-to-treat multiple myeloma produces sustained remissions
Dual-targeted antibody mosunetuzumab elicits durable responses in poor-prognosis non-Hodgkin Lymphoma patients
Multiple myeloma patients treated with BCMA-directed CAR T-cell therapy have high response rate
Cellular immunotherapy for B cell cancers shows promise
Luspatercept reduces need for blood transfusions in beta thalassemia and MDS
Results from the Medalist trial for patients with anaemia in MDS
Initial report of the Beat AML umbrella study for previously untreated AML
Diversity of gut microbiota linked with complications from haematopoietic cell transplantation
